Defunct Company
Total Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
662
NCT00877838
Study of the Safety and Effectiveness of NXN-188 for the Acute Treatment of Migraine Attacks With Aura
Phase: Phase 2
Role: Collaborator
Start: May 31, 2009
Completion: Dec 31, 2010
NCT00920686
Study of NXN 188 for the Treatment of Migraine With Aura
Role: Lead Sponsor
Start: Jun 30, 2009
Completion: Mar 31, 2010
NCT00959751
Study of the Safety and Effectiveness of NXN-188 for the Treatment of Migraine Headache Without Aura
Start: Jul 31, 2009
NCT01748877
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Start: Jan 31, 2013
Completion: Jun 30, 2014